We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.07%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$7.57B
AUM Growth
+$643M
(+9.3%)
Cap. Flow
+$235M
Cap. Flow
% of AUM
3.1%
Top 10 Holdings %
Top 10 Hldgs %
16.13%
Holding
1,154
New
305
Increased
228
Reduced
235
Closed
370
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$71M |
| 2 |
Baxter International
BAX
|
+$60.7M |
| 3 |
T-Mobile US
TMUS
|
+$60.1M |
| 4 |
Perrigo
PRGO
|
+$53.7M |
| 5 |
NRG Energy
NRG
|
+$50.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$68.2M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$53.3M |
| 3 |
Avient
AVNT
|
+$45.7M |
| 4 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$45.6M |
| 5 |
BHI
Baker Hughes
BHI
|
+$40.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.11% |
| 2 | Industrials | 11.84% |
| 3 | Consumer Discretionary | 11.65% |
| 4 | Technology | 10.61% |
| 5 | Financials | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Williams-Sonoma
WSM
$29.3B
| $11.5M | 0.15% |
303,580
+283,750
| +1,431% | +$9.84M |
|
|
CYT
177
DELISTED
CYTEC INDS INC
CYT
| $11.4M | 0.15% |
246,381
-184,381
| -43% | -$8.58M |
|
178
Huntsman Corp
HUN
$1.83B
| $11.3M | 0.15% |
494,108
+449,519
| +1,008% | +$10.9M |
|
179
3M
MMM
$93.6B
| $11.2M | 0.15% |
+81,708
| New | +$10.5M |
|
|
LXFT
180
DELISTED
Luxoft Holding, Inc.
LXFT
| $11.2M | 0.15% |
289,623
+281,016
| +3,265% | +$10.6M |
|
181
SiriusXM
SIRI
$10.4B
| $11.1M | 0.15% |
317,159
-312,945
| -50% | -$10.8M |
|
|
AIRM
182
DELISTED
Air Methods Corp
AIRM
| $10.9M | 0.14% |
248,612
+154,530
| +164% | +$7.23M |
|
|
TWX
183
DELISTED
Time Warner Inc
TWX
| $10.9M | 0.14% |
127,857
+28,460
| +29% | +$2.27M |
|
184
Icon
ICLR
$12.1B
| $10.7M | 0.14% |
210,749
+28,887
| +16% | +$1.56M |
|
185
State Street
STT
$50.9B
| $10.6M | 0.14% |
+134,628
| New | +$10.1M |
|
|
FOLD
186
DELISTED
Amicus Therapeutics
FOLD
| $10.6M | 0.14% |
+1,269,229
| New | +$8.71M |
|
187
BioMarin Pharmaceuticals
BMRN
$11.7B
| $10.5M | 0.14% |
116,280
-136,881
| -54% | -$11.4M |
|
|
PCH
188
DELISTED
PotlatchDeltic
PCH
| $10.4M | 0.14% |
248,946
+148,769
| +149% | +$6.26M |
|
|
BLUE
189
DELISTED
bluebird bio
BLUE
| $10.3M | 0.14% |
8,648
+8,508
| +6,077% | +$5.69M |
|
|
BDSI
190
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $10.3M | 0.14% |
854,206
+524,208
| +159% | +$7.97M |
|
191
UMB Financial
UMBF
$11.3B
| $10.1M | 0.13% |
178,324
+73,611
| +70% | +$4.15M |
|
192
Chevron
CVX
$379B
| $10.1M | 0.13% |
+90,048
| New | +$10.2M |
|
193
DHT Holdings
DHT
$2.92B
| $10.1M | 0.13% |
1,379,017
+747,855
| +118% | +$4.74M |
|
194
Amgen
AMGN
$210B
| $9.97M | 0.13% |
62,593
-199,926
| -76% | -$31.2M |
|
|
WMGI
195
DELISTED
Wright Medical Group Inc
WMGI
| $9.93M | 0.13% |
+369,430
| New | +$10.8M |
|
196
Enanta Pharmaceuticals
ENTA
$387M
| $9.9M | 0.13% |
194,728
-121,698
| -38% | -$5.45M |
|
|
DCH
197
Dauch Corp
DCH
$1.42B
| $9.84M | 0.13% |
+435,760
| New | +$8.67M |
|
198
RTX Corp
RTX
$294B
| $9.7M | 0.13% |
133,983
+118,346
| +757% | +$8.07M |
|
|
AMAG
199
DELISTED
AMAG Pharmaceuticals
AMAG
| $9.66M | 0.13% |
+226,744
| New | +$8.19M |
|
|
TUMI
200
DELISTED
TUMI HLDGS INC COM
TUMI
| $9.64M | 0.13% |
406,189
-665,694
| -62% | -$14.1M |
|
Similar funds
Marshall Wace's Q4 2014 Portfolio in Review
As of Q4 2014, Marshall Wace held 1,154 positions worth $7.57B, up 9.3% from $6.93B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $235M of net new capital in Q4 2014, opening 305 new positions and adding to 228 existing holdings. Its largest new stake was Baxter International: 1,557,838 shares worth $62M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Alibaba, an estimated $68.2M trimmed.
- Marshall Wace's largest Q4 2014 buy was Baxter International: 1,557,838 shares worth $62M.
- Marshall Wace added most to Allergan Inc in Q4 2014, an estimated $71M increase.
- Marshall Wace's biggest Q4 2014 reduction was Alibaba, cutting an estimated $68.2M.
- Marshall Wace fully exited Baker Hughes in Q4 2014, selling an estimated $40.5M.
- Marshall Wace's ten largest holdings make up 16% of its $7.57B portfolio in Q4 2014.
- Marshall Wace opened 305 new positions and closed 370 in Q4 2014.
- Marshall Wace's portfolio value rose 9.3% quarter-over-quarter to $7.57B.
Based on Marshall Wace's 13F filing for Q4 2014, filed 17 Feb 2015.